Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2012
02/09/2012US20120034711 Digital immunochromatographic test strip for semi-quantitative detection of aflatoxin B1 and preparation method thereof
02/09/2012US20120034710 Detection of Degradation Products of NT-proBNP
02/09/2012US20120034709 surface modified substrate, biotip and a method for producing thereof
02/09/2012US20120034708 Sample Carrier for Effecting Chemical Assays
02/09/2012US20120034706 Method for assessing inflammatory condition
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034689 Mycobacterial antigens expressed during latency
02/09/2012US20120034684 Magnetic immunosensor with trench configuration and method of use
02/09/2012US20120034645 Method and apparatuses for conducting assays
02/09/2012US20120034644 Identifying material from a breast duct
02/09/2012US20120034643 Fluorescent protein
02/09/2012US20120034641 Biological information acquisition method
02/09/2012US20120034633 Magnetic immunosensor and method of use
02/09/2012US20120034631 Anti-lysophospholipid antibody design using antibody structures
02/09/2012US20120034630 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD)
02/09/2012US20120034629 Prediction of non-fatal and fatal atherothrombotic events
02/09/2012US20120034628 Standardized evaluation of therapeutic efficacy based on cellular biomarkers
02/09/2012US20120034627 Diagnosis of benign and cancerous growths by measuring circulation tumor stem cells and serum annexina2
02/09/2012US20120034626 Neoplasia-Specific Autoantibodies and Methods
02/09/2012US20120034625 Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1
02/09/2012US20120034624 Oscillating immunoassay method and device
02/09/2012US20120034623 Up-concentration of organiz microobjects for microscopic imaging
02/09/2012US20120034622 Activation and monitoring of cellular transmembrane potentials
02/09/2012US20120034621 Microorganism concentration process and device
02/09/2012US20120034620 Compositions and methods for adhesion of intact cells to an apparatus
02/09/2012US20120034619 Method of determining the oligomeric state of a protein complex
02/09/2012US20120034617 Assays for bacterial detection and identification
02/09/2012US20120034616 Method for Modulating Epithelial Stem Cell Lineage
02/09/2012US20120034615 Hifu induced cavitation with reduced power threshold
02/09/2012US20120034614 Early detection of pathogens in blood
02/09/2012US20120034611 Method for detecting presumed iga nephropathy and method for screening iga nephropathy patients
02/09/2012US20120034610 Identification of toxin-binding protein involved in resistance to cry1 toxins, and related screening methods
02/09/2012US20120034604 Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
02/09/2012US20120034601 Porous Materials for Biological Sample Collection
02/09/2012US20120034599 Screening systems utilizing rtp801
02/09/2012US20120034349 Distinguishing abutting food product
02/09/2012US20120034318 Diagnostic method using palb2
02/09/2012US20120034317 Prediction of Response to Platinum-Based Therapy
02/09/2012US20120034254 Antigenic cloaking and its use
02/09/2012US20120034240 Perlecan as a biomarker for renal dysfunction
02/09/2012US20120034236 Co-targeting of aurora a kinase and lim kinase 1 for cancer therapy
02/09/2012US20120034235 Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker
02/09/2012US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5
02/09/2012US20120034227 Monoclonal antibody therapy for pancreas cancer
02/09/2012US20120034226 Diagnostic method of skin inflammatory disease
02/09/2012US20120034219 Uses of il-23 agonists and antagonists; related reagents
02/09/2012US20120034218 RBM3 in Colorectal Cancer Prognostics
02/09/2012US20120034210 Compositions for potentiating apoposis signals in tumour cells
02/09/2012US20120034206 Breast cancer eradication program
02/09/2012US20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof
02/09/2012US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof
02/09/2012US20120034167 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
02/09/2012US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
02/09/2012US20120034163 Non-invasive tools for detecting vulnerable atherosclerotic plaques
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/09/2012US20120034132 Magnetic Particle Resuspension Probe Module
02/09/2012US20120031841 Device and method for measuring a blood constituent in blood for an extracorporeal blood treating device
02/09/2012US20120031777 Control and calibration solutions and methods for their use
02/09/2012US20120031776 Transient Decay Amperometry
02/09/2012US20120031773 Immunoassay method and device with magnetically susceptible bead capture
02/09/2012US20120031540 Paint swatch test device and method
02/09/2012US20120031166 Beverage disguise for hand held breathalyzer interface of ignition interlock device
02/09/2012US20120031165 Breath sampling methodology having improved reliability
02/09/2012DE202010017537U1 Nachweisvorrichtung zur Bestimmung des Urea-Gehalts Detection apparatus for determining the urea content
02/09/2012DE112010000814T5 Immunanalytisches Verfahren und immunanalytisches System mit Verwendung der Massenspektrometertechnologie Immune analytical method and analytical immune system using the mass spectrometer technology
02/09/2012DE102010038842A1 New aptamer that specifically binds to human tau protein or its fragment, useful e.g. in vitro for isolating, purifying and/or detecting tau protein, and to treat cerebral infarction, pick disease and/or progressive supranuclear palsy
02/09/2012CA2817925A1 Compositions and methods for detecting, diagnosing, and treating cancer
02/09/2012CA2807514A1 Biomarkers for prostate cancer and methods for their detection
02/09/2012CA2807240A1 Detection of degradation products of canine nt-probnp
02/09/2012CA2807228A1 Method and apparatus for automated whole blood sample analyses from microscopy images
02/09/2012CA2807149A1 Novel treatment of prostate carcinoma
02/09/2012CA2807117A1 Systems and methods for improved accuracy for temperature correction of glucose results for control solution
02/09/2012CA2807107A1 Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof
02/09/2012CA2807014A1 Dual variable domain immunoglobulins and uses thereof
02/09/2012CA2806887A1 Sorting mined material
02/09/2012CA2806734A1 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
02/09/2012CA2806726A1 Prediction of and monitoring cancer therapy response based on gene expression profiling
02/09/2012CA2806670A1 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
02/09/2012CA2806491A1 Simultaneous determination of multiple analytes in industrial water system
02/09/2012CA2806460A1 Apparatus and method for testing multiple samples
02/09/2012CA2806440A1 Identification of t cell target antigens
02/09/2012CA2806029A1 Antibodies relating to pivka-ii and uses thereof
02/09/2012CA2802273A1 Perlecan as a biomarker for renal dysfunction
02/08/2012EP2416159A1 Method for detecting antibody against sith-1 in biological sample
02/08/2012EP2416158A1 Method for detecting substance in biological sample
02/08/2012EP2416157A2 Method and compositions for specifically detecting physiologically acceptable polymer molecules
02/08/2012EP2416156A1 Method for determining a male fertility status
02/08/2012EP2416155A1 Selecting sperm cells in a sperm cell population for use in an assited reproduction technique
02/08/2012EP2416154A1 Method and apparatuses for predicting the effects of erythropoesis stimulating agents (ESA), and for determining a dose to be administered
02/08/2012EP2416153A1 Method for predicting the quality and yields of a crude oil
02/08/2012EP2416152A1 Improvements relating to hydrocarbon recovery
02/08/2012EP2416147A1 Sensor device and manufacturing method
02/08/2012EP2416127A1 A method and a device for measuring component fractions in a multi-phase flow
02/08/2012EP2415877A2 Means and methods for diagnosing pancreatic cancer
02/08/2012EP2415876A1 Highly sensitive detection method for highly virulent oral cavity bacteria
02/08/2012EP2415874A1 Method for testing drug sensitivity and device thereof
02/08/2012EP2415868A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
02/08/2012EP2415679A1 Ultrasound sensor
02/08/2012EP2415517A1 Process for making array
02/08/2012EP2415486A2 Conjugates and compositions for cellular delivery
1 ... 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 ... 3937